CTE — Cryosite Cashflow Statement
0.000.00%
- AU$36.61m
- AU$34.29m
- AU$12.61m
- 99
- 40
- 30
- 59
Annual cashflow statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 1.01 | 0.05 | 0 | — | — |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.32 | 0.515 | 2.52 | 1.41 | 2.74 |
Capital Expenditures | -0.91 | -0.397 | -0.863 | -0.301 | -0.452 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | 0.028 | 0.023 | 0.003 | -0.922 | 1.18 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.882 | -0.374 | -0.86 | -1.22 | 0.727 |
Financing Cash Flow Items | -0.038 | -0.035 | -0.005 | -0.028 | -2.47 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.292 | -0.295 | -0.181 | -0.796 | -3.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.142 | -0.181 | 1.46 | -0.61 | -0.028 |